These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 33852752)

  • 1. Cortico-subcortical functional connectivity modifications in fatigued multiple sclerosis patients treated with fampridine and amantadine.
    Rocca MA; Valsasina P; Colombo B; Martinelli V; Filippi M
    Eur J Neurol; 2021 Jul; 28(7):2249-2258. PubMed ID: 33852752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional connectivity modifications in monoaminergic circuits occur in fatigued MS patients treated with fampridine and amantadine.
    Rocca MA; Valsasina P; Lamanna MT; Colombo B; Martinelli V; Filippi M
    J Neurol; 2023 Oct; 270(10):4697-4706. PubMed ID: 37462753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Abnormal functional connectivity of thalamic sub-regions contributes to fatigue in multiple sclerosis.
    Hidalgo de la Cruz M; d'Ambrosio A; Valsasina P; Pagani E; Colombo B; Rodegher M; Falini A; Comi G; Filippi M; Rocca MA
    Mult Scler; 2018 Aug; 24(9):1183-1195. PubMed ID: 28657428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional connectivity dynamics reflect disability and multi-domain clinical impairment in patients with relapsing-remitting multiple sclerosis.
    Romanello A; Krohn S; von Schwanenflug N; Chien C; Bellmann-Strobl J; Ruprecht K; Paul F; Finke C
    Neuroimage Clin; 2022; 36():103203. PubMed ID: 36179389
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dynamic functional connectivity as a neural correlate of fatigue in multiple sclerosis.
    Tijhuis FB; Broeders TAA; Santos FAN; Schoonheim MM; Killestein J; Leurs CE; van Geest Q; Steenwijk MD; Geurts JJG; Hulst HE; Douw L
    Neuroimage Clin; 2021; 29():102556. PubMed ID: 33472144
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Monoaminergic network abnormalities: a marker for multiple sclerosis-related fatigue and depression.
    Carotenuto A; Valsasina P; Preziosa P; Mistri D; Filippi M; Rocca MA
    J Neurol Neurosurg Psychiatry; 2023 Feb; 94(2):94-101. PubMed ID: 36229193
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fatigue in multiple sclerosis: The contribution of resting-state functional connectivity reorganization.
    Bisecco A; Nardo FD; Docimo R; Caiazzo G; d'Ambrosio A; Bonavita S; Capuano R; Sinisi L; Cirillo M; Esposito F; Tedeschi G; Gallo A
    Mult Scler; 2018 Nov; 24(13):1696-1705. PubMed ID: 28911257
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of modified-release fampridine on upper limb impairment in patients with Multiple Sclerosis.
    Marion S; Leonid C; Belinda B; Joanne D; Elise H; Leeanne C; Richard M
    Mult Scler Relat Disord; 2020 May; 40():101971. PubMed ID: 32062444
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resting-state functional connectivity networks associated with fatigue in multiple sclerosis with early age onset.
    Stefancin P; Govindarajan ST; Krupp L; Charvet L; Duong TQ
    Mult Scler Relat Disord; 2019 Jun; 31():101-105. PubMed ID: 30954931
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes of brain resting state functional connectivity predict the persistence of cognitive rehabilitation effects in patients with multiple sclerosis.
    Parisi L; Rocca MA; Mattioli F; Copetti M; Capra R; Valsasina P; Stampatori C; Filippi M
    Mult Scler; 2014 May; 20(6):686-94. PubMed ID: 24072724
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neural distinctiveness of fatigue and low sleep quality in multiple sclerosis.
    Ruiz-Rizzo AL; Bublak P; Kluckow S; Finke K; Gaser C; Schwab M; Güllmar D; Müller HJ; Witte OW; Rupprecht S
    Eur J Neurol; 2022 Oct; 29(10):3017-3027. PubMed ID: 35699354
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluating the effects of amantadin, modafinil and acetyl-L-carnitine on fatigue in multiple sclerosis--result of a pilot randomized, blind study.
    Ledinek AH; Sajko MC; Rot U
    Clin Neurol Neurosurg; 2013 Dec; 115 Suppl 1():S86-9. PubMed ID: 24321164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacological treatments for fatigue in patients with multiple sclerosis: A systematic review and meta-analysis.
    Yang TT; Wang L; Deng XY; Yu G
    J Neurol Sci; 2017 Sep; 380():256-261. PubMed ID: 28870581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Functional network connectivity abnormalities in multiple sclerosis: Correlations with disability and cognitive impairment.
    Rocca MA; Valsasina P; Leavitt VM; Rodegher M; Radaelli M; Riccitelli GC; Martinelli V; Martinelli-Boneschi F; Falini A; Comi G; Filippi M
    Mult Scler; 2018 Apr; 24(4):459-471. PubMed ID: 28294693
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Resting state functional connectivity modifications in monoaminergic circuits underpin fatigue development in patients with multiple sclerosis.
    Margoni M; Valsasina P; Bacchetti A; Mistri D; Preziosa P; Rocca MA; Filippi M
    Mol Psychiatry; 2024 Mar; ():. PubMed ID: 38528072
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of Fampridine-SR on cognitive fatigue in a randomized double-blind crossover trial in patients with MS.
    Morrow SA; Rosehart H; Johnson AM
    Mult Scler Relat Disord; 2017 Jan; 11():4-9. PubMed ID: 28104253
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Short-term impact of fampridine on motor and cognitive functions, mood and quality of life among multiple sclerosis patients.
    Pavsic K; Pelicon K; Ledinek AH; Sega S
    Clin Neurol Neurosurg; 2015 Dec; 139():35-40. PubMed ID: 26363365
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structural and functional magnetic resonance imaging correlates of fatigue and dual-task performance in progressive multiple sclerosis.
    Preziosa P; Rocca MA; Pagani E; Valsasina P; Amato MP; Brichetto G; Bruschi N; Chataway J; Chiaravalloti ND; Cutter G; Dalgas U; DeLuca J; Farrell R; Feys P; Freeman J; Inglese M; Meani A; Meza C; Motl RW; Salter A; Sandroff BM; Feinstein A; Filippi M;
    J Neurol; 2023 Mar; 270(3):1543-1563. PubMed ID: 36436069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dynamic Functional Connectivity in the Main Clinical Phenotypes of Multiple Sclerosis.
    Hidalgo de la Cruz M; Valsasina P; Sangalli F; Esposito F; Rocca MA; Filippi M
    Brain Connect; 2021 Oct; 11(8):678-690. PubMed ID: 33813839
    [No Abstract]   [Full Text] [Related]  

  • 20. Treatment of fatigue with methylphenidate, modafinil and amantadine in multiple sclerosis (TRIUMPHANT-MS): Study design for a pragmatic, randomized, double-blind, crossover clinical trial.
    Nourbakhsh B; Revirajan N; Waubant E
    Contemp Clin Trials; 2018 Jan; 64():67-76. PubMed ID: 29113955
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.